ReviewBiochimica et biophysica acta. Reviews on cancer2021

FGFR signaling and endocrine resistance in breast cancer: Challenges for the clinical development of FGFR inhibitors.

Alberto Servetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.